SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in JANX — Janux Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,654,864
+$1,168,594 QoQ
Shares Held
119,055
+237.9% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Derivatives in JANX
reported options exposure · as of Mar 31, 2026CallValue
$3,416,620
CallShares
245,800
PutValue
$5,038,750
PutShares
362,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. JANX ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in JANX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,416,620 | 245,800 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $5,038,750 | 362,500 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $1,654,864 | 119,055 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,932,500 | 212,500 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $4,146,900 | 300,500 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $486,270 | 35,237 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,083,924 | 167,100 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $4,133,806 | 169,141 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $1,163,344 | 47,600 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $5,312,745 | 229,989 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $2,363,130 | 102,300 | Put | Other | 2025-08-14 | |
| 2025-06-30 | $1,450,680 | 62,800 | Call | Other | 2025-08-14 | |
| 2025-03-31 | $2,365,200 | 87,600 | Put | Other | 2025-05-14 | |
| 2025-03-31 | $9,961,245 | 368,935 | Shares | Other | 2025-05-14 | |
| 2025-03-31 | $2,991,600 | 110,800 | Call | Other | 2025-05-14 | |
| 2024-12-31 | $5,809,090 | 108,500 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $1,577,877 | 29,471 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $11,944,774 | 223,100 | Put | Other | 2025-02-14 | |
| 2024-09-30 | $2,527,634 | 55,638 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $5,406,170 | 119,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $3,634,400 | 80,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $2,303,950 | 55,000 | Call | Defined | 2024-08-15 | |
| 2024-06-30 | $2,865,276 | 68,400 | Put | Defined | 2024-08-15 | |
| 2024-06-30 | $1,073,389 | 25,624 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $2,951,760 | 78,400 | Call | Defined | 2024-05-07 | |
| 2024-03-31 | $231,660 | 6,153 | Shares | Defined | 2024-05-07 | |
| 2024-03-31 | $3,373,440 | 89,600 | Put | Defined | 2024-05-07 | |
| 2023-03-31 | $154,008 | 12,728 | Shares | Defined | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||